{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:20:16Z","timestamp":1790508016894,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00467-020-04915-7","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T15:02:58Z","timestamp":1611414178000},"page":"1795-1802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Levamisole and ANCA positivity in childhood nephrotic syndrome"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-7730","authenticated-orcid":false,"given":"Leah","family":"Krischock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasan","family":"Pannila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"4915_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/jcm8060860","volume":"8","author":"AK Muhlig","year":"2019","unstructured":"Muhlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J (2019) Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects. J Clin Med 8:860","journal-title":"J Clin Med"},{"key":"4915_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"MP Gruppen","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC (2018) A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney Int 93:510\u2013518","journal-title":"Kidney Int"},{"key":"4915_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.kint.2018.10.008","volume":"95","author":"M Vivarelli","year":"2019","unstructured":"Vivarelli M, Emma F (2019) Levamisole for children with nephrotic syndrome: new evidence for the use of an \u201cold\u201d drug. Kidney Int 95:25\u201328","journal-title":"Kidney Int"},{"key":"4915_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00467-004-1615-9","volume":"20","author":"JC Davin","year":"2005","unstructured":"Davin JC, Merkus MP (2005) Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? Pediatr Nephrol 20:10\u201314","journal-title":"Pediatr Nephrol"},{"key":"4915_CR5","unstructured":"Therapeutic Goods Administration Special Access Scheme"},{"key":"4915_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s004670050753","volume":"13","author":"G Barbano","year":"1999","unstructured":"Barbano G, Ginevri F, Ghiggeri GM, Gusmano R (1999) Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13:602\u2013603","journal-title":"Pediatr Nephrol"},{"key":"4915_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13256-018-1728-6","volume":"12","author":"B Aoun","year":"2018","unstructured":"Aoun B, Alali M, Degheili JA, Sanjad S, Vaquin C, Donadieu J, Ulinski T, Termos S (2018) Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report. J Med Case Rep 12:209","journal-title":"J Med Case Rep"},{"key":"4915_CR8","first-page":"626495","volume":"2011","author":"K Tsiveriotis","year":"2011","unstructured":"Tsiveriotis K, Tsirogianni A, Pipi E, Soufleros K, Papasteriades C (2011) Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis 2011:626495","journal-title":"Autoimmune Dis"},{"key":"4915_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"4915_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139\u2013251","journal-title":"Kidney Int Suppl"},{"key":"4915_CR11","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1046\/j.1523-1755.2001.0590051919.x","volume":"59","author":"AM Durkan","year":"2001","unstructured":"Durkan AM, Hodson EM, Willis NS, Craig JC (2001) Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 59:1919\u20131927","journal-title":"Kidney Int"},{"key":"4915_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13312-014-0419-7","volume":"51","author":"S Ekambaram","year":"2014","unstructured":"Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S (2014) Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome. Indian Pediatr 51:371\u2013373","journal-title":"Indian Pediatr"},{"key":"4915_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10157-016-1266-8","volume":"21","author":"B Basu","year":"2017","unstructured":"Basu B, Babu BG, Mahapatra TK (2017) Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children. Clin Exp Nephrol 21:143\u2013151","journal-title":"Clin Exp Nephrol"},{"key":"4915_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/0140-6736(91)93257-A","volume":"337","author":"British Association for Paediatric Nephrology","year":"1991","unstructured":"British Association for Paediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555\u20131557","journal-title":"Lancet"},{"key":"4915_CR15","first-page":"6","volume":"15","author":"H Rashid","year":"1996","unstructured":"Rashid H, Ahmed S, Fatima N, Khanam A (1996) Levamisole in the treatment of steroid dependent or frequent relapsing nephrotic syndrome in children. Bangladesh Renal J 15:6\u20138","journal-title":"Bangladesh Renal J"},{"key":"4915_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000187855","volume":"66","author":"U Dayal","year":"1994","unstructured":"Dayal U, Dayal AK, Shastry J, Raghupathy P (1994) Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Nephron 66:408\u2013412","journal-title":"Nephron"},{"key":"4915_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","volume":"95","author":"A Sinha","year":"2019","unstructured":"Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A (2019) Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Kidney Int 95:210\u2013218","journal-title":"Kidney Int"},{"key":"4915_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00467-017-3616-5","volume":"32","author":"AS Abeyagunawardena","year":"2017","unstructured":"Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S (2017) Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome. Pediatr Nephrol 32:1363\u20131367","journal-title":"Pediatr Nephrol"},{"key":"4915_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00296-019-04410-9","volume":"39","author":"F Lotscher","year":"2019","unstructured":"Lotscher F, Krusche M, Ruffer N, Kubacki T, Person F, Kotter I (2019) Cocaine-induced ANCA-associated renal disease: a case-based review. Rheumatol Int 39:2005\u20132014","journal-title":"Rheumatol Int"},{"key":"4915_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3899\/jrheum.180771","volume":"46","author":"MB Morcos","year":"2019","unstructured":"Morcos MB, Lood C, Hughes GC (2019) Demographic, clinical, and immunologic correlates among a cohort of 50 cocaine users demonstrating antineutrophil cytoplasmic antibodies. J Rheumatol 46:1151\u20131156","journal-title":"J Rheumatol"},{"key":"4915_CR21","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.amjmed.2016.11.003","volume":"130","author":"JW Digby","year":"2017","unstructured":"Digby JW, Tinwell B, Sheldon J, Wang J (2017) The missing antibody: the pitfalls of ANCA testing. Am J Med 130:e93\u2013e96","journal-title":"Am J Med"},{"key":"4915_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrrheum.2014.78","volume":"10","author":"E Csernok","year":"2014","unstructured":"Csernok E, Moosig F (2014) Current and emerging techniques for ANCA detection in vasculitis. Nat Rev Rheumatol 10:494\u2013501","journal-title":"Nat Rev Rheumatol"},{"key":"4915_CR23","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/1756-185X.13483","volume":"22","author":"G Bornstein","year":"2019","unstructured":"Bornstein G, Ben-Zvi I, Furie N, Grossman C (2019) Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis. Int J Rheum Dis 22:940\u2013945","journal-title":"Int J Rheum Dis"},{"key":"4915_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/rheumatology\/kex216","volume":"56","author":"C Lood","year":"2017","unstructured":"Lood C, Hughes GC (2017) Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatology (Oxford) 56:638\u2013643","journal-title":"Rheumatology (Oxford)"},{"key":"4915_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/20009666.2018.1536242","volume":"8","author":"Q Jin","year":"2018","unstructured":"Jin Q, Kant S, Alhariri J, Geetha D (2018) Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis. J Commun Hosp Intern Med Perspect 8:339\u2013344","journal-title":"J Commun Hosp Intern Med Perspect"},{"key":"4915_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fimmu.2016.00256","volume":"7","author":"D S\u00f6derberg","year":"2016","unstructured":"S\u00f6derberg D, Segelmark M (2016) Neutrophil extracellular traps in ANCA-associated vasculitis. Front Immunol 7:256","journal-title":"Front Immunol"},{"key":"4915_CR27","doi-asserted-by":"publisher","first-page":"e0148197","DOI":"10.1371\/journal.pone.0148197","volume":"11","author":"H Wang","year":"2016","unstructured":"Wang H, Sha LL, Ma TT, Zhang LX, Chen M, Zhao MH (2016) Circulating level of neutrophil extracellular traps is not a useful biomarker for assessing disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One 11:e0148197","journal-title":"PLoS One"},{"key":"4915_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/BOR.0000000000000450","volume":"30","author":"D S\u00f6derberg","year":"2018","unstructured":"S\u00f6derberg D, Segelmark M (2018) Neutrophil extracellular traps in vasculitis, friend or foe? Curr Opin Rheumatol 30:16\u201323","journal-title":"Curr Opin Rheumatol"},{"key":"4915_CR29","doi-asserted-by":"publisher","first-page":"e89780","DOI":"10.1172\/jci.insight.89780","volume":"2","author":"C Carmona-Rivera","year":"2017","unstructured":"Carmona-Rivera C, Purmalek MM, Moore E, Waldman M, Walter PJ, Garraffo HM, Phillips KA, Preston KL, Graf J, Kaplan MJ, Grayson PC (2017) A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity. JCI Insight 2:e89780","journal-title":"JCI Insight"},{"key":"4915_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5414\/CNP60275","volume":"60","author":"Y Kaneko","year":"2003","unstructured":"Kaneko Y, Kamijo Y, Kobayashi N, Higuchi M, Ehara T, Hora K, Shigematsu H, Kiyosawa K (2003) Younger onset myeloperoxidase-specific antineutrophil cytoplasmic antibody- (MPO-ANCA) related glomerulonephritis accompanied with nephrotic syndrome. Clin Nephrol 60:275\u2013278","journal-title":"Clin Nephrol"},{"key":"4915_CR31","first-page":"526","volume":"21","author":"WL Jabur","year":"2010","unstructured":"Jabur WL, Saeed HM (2010) ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome. Saudi J Kidney Dis Transpl 21:526\u2013530","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"4915_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0971-4065.45294","volume":"18","author":"NP Singh","year":"2008","unstructured":"Singh NP, Gulati S, Garg V, Beniwal P, Garg S (2008) Nephrotic range proteinuria in c-ANCA-positive crescentic glomerulonephritis with linear immune deposits. Indian J Nephrol 18:169\u2013172","journal-title":"Indian J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04915-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T19:31:00Z","timestamp":1622662260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04915-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4915"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04915-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"4 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by the Human Research Ethics Committee at Sydney Children\u2019s Hospital, Randwick (LNR\/15\/SCHN\/503).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}